Risperidone (Depot)
Indication
Schizophrenia
The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.
MHRA Drug Safety Update - Drug name confusion
MHRA Drug Safety Update - Risperidone and paliperidone: risk of floppy iris syndrome
Red
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
LSCMMG is adopting the local decision made prior to April 2013